219 related articles for article (PubMed ID: 24382740)
1. Epigenetic determinants of ovarian clear cell carcinoma biology.
Yamaguchi K; Huang Z; Matsumura N; Mandai M; Okamoto T; Baba T; Konishi I; Berchuck A; Murphy SK
Int J Cancer; 2014 Aug; 135(3):585-97. PubMed ID: 24382740
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.
Tsuchiya A; Sakamoto M; Yasuda J; Chuma M; Ohta T; Ohki M; Yasugi T; Taketani Y; Hirohashi S
Am J Pathol; 2003 Dec; 163(6):2503-12. PubMed ID: 14633622
[TBL] [Abstract][Full Text] [Related]
3. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.
Yamaguchi K; Mandai M; Oura T; Matsumura N; Hamanishi J; Baba T; Matsui S; Murphy SK; Konishi I
Oncogene; 2010 Mar; 29(12):1741-52. PubMed ID: 20062075
[TBL] [Abstract][Full Text] [Related]
4. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M
Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary.
Kato N; Tamura G; Motoyama T
Virchows Arch; 2008 Feb; 452(2):175-80. PubMed ID: 18066692
[TBL] [Abstract][Full Text] [Related]
6. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
Xiao W; Awadallah A; Xin W
Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
[TBL] [Abstract][Full Text] [Related]
7. Pathology of clear cell carcinoma of the ovary: A basic view based on cultured cells and modern view from comprehensive approaches.
Kato N
Pathol Int; 2020 Sep; 70(9):591-601. PubMed ID: 32476214
[TBL] [Abstract][Full Text] [Related]
8. Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.
Cuff J; Salari K; Clarke N; Esheba GE; Forster AD; Huang S; West RB; Higgins JP; Longacre TA; Pollack JR
PLoS One; 2013; 8(9):e74562. PubMed ID: 24040285
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression.
Kato N; Motoyama T
Histopathology; 2008 May; 52(6):682-8. PubMed ID: 18393978
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
Hirata Y; Murai N; Yanaihara N; Saito M; Saito M; Urashima M; Murakami Y; Matsufuji S; Okamoto A
BMC Cancer; 2014 Nov; 14():799. PubMed ID: 25366985
[TBL] [Abstract][Full Text] [Related]
12. The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary.
Kobayashi H; Yamada Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
Int J Gynecol Cancer; 2009 Apr; 19(3):471-9. PubMed ID: 19407577
[TBL] [Abstract][Full Text] [Related]
13. Theoretical model of treatment strategies for clear cell carcinoma of the ovary: focus on perspectives.
Yoshida S; Furukawa N; Haruta S; Tanase Y; Kanayama S; Noguchi T; Sakata M; Yamada Y; Oi H; Kobayashi H
Cancer Treat Rev; 2009 Nov; 35(7):608-15. PubMed ID: 19665848
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma.
Ho CM; Huang CJ; Huang CY; Wu YY; Chang SF; Cheng WF
Mol Cancer; 2012 Aug; 11():53. PubMed ID: 22871047
[TBL] [Abstract][Full Text] [Related]
16. DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma.
Kuo KT; Mao TL; Chen X; Feng Y; Nakayama K; Wang Y; Glas R; Ma MJ; Kurman RJ; Shih IeM; Wang TL
Clin Cancer Res; 2010 Apr; 16(7):1997-2008. PubMed ID: 20233889
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.
Cunningham JM; Winham SJ; Wang C; Weiglt B; Fu Z; Armasu SM; McCauley BM; Brand AH; Chiew YE; Elishaev E; Gourley C; Kennedy CJ; Laslavic A; Lester J; Piskorz A; Sekowska M; Brenton JD; Churchman M; DeFazio A; Drapkin R; Elias KM; Huntsman DG; Karlan BY; Köbel M; Konner J; Lawrenson K; Papaemmanuil E; Bolton KL; Modugno F; Goode EL
Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):132-141. PubMed ID: 34697060
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
[TBL] [Abstract][Full Text] [Related]
19. BRCA2 alteration is important in clear cell carcinoma of the ovary.
Goodheart MJ; Rose SL; Hattermann-Zogg M; Smith BJ; De Young BR; Buller RE
Clin Genet; 2009 Aug; 76(2):161-7. PubMed ID: 19656163
[TBL] [Abstract][Full Text] [Related]
20. A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.
Wiegand KC; Hennessy BT; Leung S; Wang Y; Ju Z; McGahren M; Kalloger SE; Finlayson S; Stemke-Hale K; Lu Y; Zhang F; Anglesio MS; Gilks B; Mills GB; Huntsman DG; Carey MS
BMC Cancer; 2014 Feb; 14():120. PubMed ID: 24559118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
